{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:44:05Z","timestamp":1794606245097,"version":"4.9.1"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>Beh\u00e7et\u2019s disease is a rare and recurrent multisystem inflammatory disorder, primarily distinguished by systemic vasculitis that affects veins and arteries of various sizes. Clinically, Beh\u00e7et\u2019s disease is characterized by the presence of recurrent oral and genital ulcers, skin lesions, and uveitis. The prevalence of this condition is significantly elevated along the historical Silk Road, particularly in Turkey; however, epidemiological data indicate variations across different regions and ethnic groups. The diagnosis of Beh\u00e7et\u2019s disease is typically established during the third decade of life, with a more severe prognosis noted when the onset occurs before the age of 25. This review aims to explore the epidemiology, pathogenesis, clinical manifestations, diagnostic criteria, and current therapeutic strategies relevant to Beh\u00e7et\u2019s disease. Specific attention is devoted to understanding the global distribution of the disease, its associated morbidity patterns, and current management and treatment modalities.<\/jats:p>","DOI":"10.1097\/md.0000000000044614","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:03:10Z","timestamp":1764972190000},"page":"e44614","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Beh\u00e7et\u2019s disease unraveled: Insights into clinical manifestations, diagnosis, and management"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7938-3523","authenticated-orcid":false,"given":"Mansour","family":"Alghamdi","sequence":"first","affiliation":[{"name":"Department of Medicine, Louisiana State University Health Science Center, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lindsey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Louisiana State University Health Science Center, New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41572-021-00301-1","article-title":"Beh\u00e7et syndrome.","volume":"7","author":"Yazici","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/medicina60040562","article-title":"Beh\u00e7et\u2019s disease, pathogenesis, clinical features, and treatment approaches: a comprehensive review.","volume":"60","author":"Lavalle","year":"2024","journal-title":"Medicina (Kaunas)"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides.","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMra2305712","article-title":"Beh\u00e7et\u2019s syndrome.","volume":"390","author":"Saadoun","year":"2024","journal-title":"N Engl J Med"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/BOR.0000000000000349","article-title":"Behcet\u2019s syndrome in nonendemic regions.","volume":"29","author":"Leccese","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13075-021-02615-7","article-title":"Epidemiology and treatment of Beh\u00e7et\u2019s disease in the USA: insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry with a comparison with other published cohorts from endemic regions.","volume":"23","author":"Hammam","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1002\/acr.23089","article-title":"Rheumatology Informatics System for Effectiveness: a national informatics-enabled registry for quality improvement.","volume":"68","author":"Yazdany","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.berh.2018.08.010","article-title":"Update on the epidemiology, risk factors and disease outcomes of Beh\u00e7et\u2019s disease.","volume":"32","author":"Akko\u00e7","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","article-title":"Exploring the variability in Beh\u00e7et\u2019s disease prevalence: a meta-analytical approach.","volume":"57","author":"Maldini","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"586558","DOI":"10.3389\/fimmu.2020.586558","article-title":"Understanding Beh\u00e7et\u2019s disease in the context of innate immunity activation.","volume":"11","author":"Perazzio","year":"2020","journal-title":"Front Immunol"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies.","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"590622","DOI":"10.3389\/fimmu.2020.590622","article-title":"Neutrophil extracellular traps promote aberrant macrophages activation in Beh\u00e7et\u2019s disease.","volume":"11","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"R14-20260523","first-page":"363859","article-title":"Skewed helper T-cell responses to IL-12 family cytokines produced by antigen-presenting cells and the genetic background in Behcet\u2019s disease.","volume":"2013","author":"Shimizu","year":"2013","journal-title":"Genet Res Int"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","article-title":"Beh\u00e7et\u2019s syndrome.","volume":"403","author":"Emmi","year":"2024","journal-title":"Lancet"},{"key":"R16-20260523","first-page":"1078","article-title":"Criteria for diagnosis of Behc\u0327et\u2019s disease.","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Behc\u0327et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1093\/rheumatology\/keac018","article-title":"Evaluation of sensitivity and specificity of diagnostic criteria for Beh\u00e7et\u2019s disease in the absence of a gold standard.","volume":"61","author":"Zhong","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40257-021-00609-4","article-title":"Beh\u00e7et disease: an update for dermatologists.","volume":"22","author":"Alpsoy","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"613432","DOI":"10.3389\/fmed.2020.613432","article-title":"Mucocutaneous manifestations of Beh\u00e7et\u2019s disease.","volume":"7","author":"Nakamura","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R21-20260523","first-page":"482","article-title":"Epididymo-orchitis in Bechet\u2019s disease: a review of the wide spectrum of the disease.","volume":"55","author":"Kanakis","year":"2017","journal-title":"Acta Med Iran"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/01.ju.0000081957.90395.4c","article-title":"Clinical features of patients with Beh\u00e7et\u2019s disease and epididymitis.","volume":"170","author":"Cho","year":"2003","journal-title":"J Urol"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1468-3083.2003.00625.x","article-title":"Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Beh\u00e7et\u2019s disease.","volume":"17","author":"Alpsoy","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1365-4632.2006.02797.x","article-title":"Can specific vessel-based papulopustular lesions of Beh\u00e7et\u2019s disease be differentiated from nonspecific follicular-based lesions clinically?","volume":"45","author":"Boyvat","year":"2006","journal-title":"Int J Dermatol"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.60.11.1074","article-title":"Papulopustular skin lesions are seen more frequently in patients with Beh\u00e7et\u2019s syndrome who have arthritis: a controlled and masked study.","volume":"60","author":"Diri","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000372-200010000-00001","article-title":"Histopathologic features of erythema nodosum--like lesions in Beh\u00e7et disease: a comparison with erythema nodosum focusing on the role of vasculitis.","volume":"22","author":"Kim","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2133.1985.tb02082.x","article-title":"Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet\u2019s disease.","volume":"113","author":"Kaneko","year":"1985","journal-title":"Br J Dermatol"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2340\/00015555-1349","article-title":"Erythema nodosum-like lesions in Beh\u00e7et\u2019s disease: a clinicopathological study of 26 cases.","volume":"92","author":"Misago","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"R29-20260523","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1742-1241.2005.00286.x","article-title":"Are erythema nodosum-like lesions and superficial thrombophlebitis prodromal in terms of visceral involvement in Behcet\u2019s disease?","volume":"59","author":"Coskun","year":"2005","journal-title":"Int J Clin Pract"},{"key":"R30-20260523","doi-asserted-by":"crossref","first-page":"639404","DOI":"10.3389\/fmed.2021.639404","article-title":"Pathergy phenomenon.","volume":"8","author":"Ergun","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R31-20260523","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10067-011-1694-5","article-title":"Diagnostic value of pathergy test in Behcet\u2019s disease according to the change of incidence over the time.","volume":"30","author":"Davatchi","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R32-20260523","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/rheumatology\/keac543","article-title":"Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Beh\u00e7et disease.","volume":"62","author":"Deniz","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R33-20260523","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","article-title":"Beh\u00e7et\u2019s syndrome.","volume":"22","author":"Yurdakul","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R34-20260523","doi-asserted-by":"crossref","first-page":"639758","DOI":"10.3389\/fmed.2021.639758","article-title":"Beh\u00e7et\u2019s syndrome apart from the triple symptom complex: vascular, neurologic, gastrointestinal, and musculoskeletal manifestations. A mini review.","volume":"8","author":"K\u00f6tter","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R35-20260523","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/ard.40.6.558","article-title":"A controlled survey of sacroiliitis in Behcet\u2019s disease.","volume":"40","author":"Yazici","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"R36-20260523","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/art.23450","article-title":"Increased enthesopathy among Beh\u00e7et\u2019s syndrome patients with acne and arthritis: an ultrasonography study.","volume":"58","author":"Hatemi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R37-20260523","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/08830189709116845","article-title":"Uveitis in Beh\u00e7et\u2019s disease.","volume":"14","author":"Nussenblatt","year":"1997","journal-title":"Int Rev Immunol"},{"key":"R38-20260523","doi-asserted-by":"crossref","first-page":"101216","DOI":"10.1016\/j.preteyeres.2023.101216","article-title":"Risk factors, clinical features and treatment of Beh\u00e7et\u2019s disease uveitis.","volume":"97","author":"Zhong","year":"2023","journal-title":"Prog Retin Eye Res"},{"key":"R39-20260523","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients.","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R40-20260523","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/09273948.2013.795228","article-title":"Differential diagnosis of Beh\u00e7et uveitis.","volume":"21","author":"Tugal-Tutkun","year":"2013","journal-title":"Ocul Immunol Inflamm"},{"key":"R41-20260523","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41584-022-00880-7","article-title":"Vascular Beh\u00e7et syndrome: from pathogenesis to treatment.","volume":"19","author":"Bettiol","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R42-20260523","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10067-013-2205-7","article-title":"Major vascular involvement in Beh\u00e7et\u2019s disease: a retrospective study of 796 patients.","volume":"32","author":"Fei","year":"2013","journal-title":"Clin Rheumatol"},{"key":"R43-20260523","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","article-title":"Vascular involvement in Beh\u00e7et\u2019s syndrome: a retrospective analysis of associations and the time course.","volume":"53","author":"Tascilar","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R44-20260523","first-page":"858","article-title":"Budd-Chiari syndrome: a common complication of Beh\u00e7et\u2019s disease.","volume":"92","author":"Bayraktar","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"R45-20260523","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1378\/chest.127.6.2243","article-title":"Pulmonary vasculitis in behcet disease: a cumulative analysis.","volume":"127","author":"Uzun","year":"2005","journal-title":"Chest"},{"key":"R46-20260523","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MD.0b013e318242ff37","article-title":"Pulmonary artery involvement and associated lung disease in Beh\u00e7et disease: a series of 47 patients.","volume":"91","author":"Seyahi","year":"2012","journal-title":"Medicine (Baltim)"},{"key":"R47-20260523","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1172-6-15","article-title":"Hughes-Stovin syndrome.","volume":"6","author":"Khalid","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"R48-20260523","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of Neuro-Beh\u00e7et\u2019s disease: international consensus recommendations.","volume":"261","author":"Kalra","year":"2014","journal-title":"J Neurol"},{"key":"R49-20260523","doi-asserted-by":"crossref","first-page":"e0218652","DOI":"10.1371\/journal.pone.0218652","article-title":"Increased ischemic stroke risk in patients with Beh\u00e7et\u2019s disease: a nationwide population-based cohort study.","volume":"14","author":"Wu","year":"2019","journal-title":"PLoS One"},{"key":"R50-20260523","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1177\/1352458515613642","article-title":"Spinal cord involvement in Beh\u00e7et\u2019s disease.","volume":"22","author":"Lee","year":"2016","journal-title":"Mult Scler"},{"key":"R51-20260523","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1179\/2045772314Y.0000000209","article-title":"Recurrent longitudinal extensive transverse myelitis in a neuro-Beh\u00e7et syndrome treated with infliximab.","volume":"38","author":"Uyguno\u011flu","year":"2015","journal-title":"J Spinal Cord Med"},{"key":"R52-20260523","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10067-005-0070-8","article-title":"CNS involvement occurs more frequently in patients with Beh\u00e7et\u2019s disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.","volume":"25","author":"K\u00f6tter","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R53-20260523","doi-asserted-by":"crossref","first-page":"101674","DOI":"10.1016\/j.disamonth.2023.101674","article-title":"Gastrointestinal Beh\u00e7et\u2019s disease: manifestations, diagnosis, and management.","volume":"70","author":"Manuelyan","year":"2024","journal-title":"Dis Mon"},{"key":"R54-20260523","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.3748\/wjg.v21.i13.3801","article-title":"Gastrointestinal Beh\u00e7et\u2019s disease: a review.","volume":"21","author":"Skef","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R55-20260523","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2040622314523062","article-title":"Update on the therapy of Beh\u00e7et disease.","volume":"5","author":"Saleh","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"key":"R56-20260523","doi-asserted-by":"crossref","first-page":"624795","DOI":"10.3389\/fmed.2021.624795","article-title":"Treatment of Beh\u00e7et\u2019s disease: an algorithmic multidisciplinary approach.","volume":"8","author":"Alpsoy","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R57-20260523","doi-asserted-by":"crossref","first-page":"iii108","DOI":"10.1093\/rheumatology\/keaa086","article-title":"Management of Behcet\u2019s syndrome.","volume":"59","author":"Karadag","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R58-20260523","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome.","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R59-20260523","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","article-title":"Trial of apremilast for oral ulcers in Beh\u00e7et\u2019s syndrome.","volume":"381","author":"Hatemi","year":"2019","journal-title":"N Engl J Med"},{"key":"R60-20260523","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1002\/art.34450","article-title":"Immunosuppressants reduce venous thrombosis relapse in Beh\u00e7et\u2019s disease.","volume":"64","author":"Desbois","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R61-20260523","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/BOR.0000000000000231","article-title":"Management of Beh\u00e7et\u2019s syndrome.","volume":"28","author":"Ozguler","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R62-20260523","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/rheumatology\/keab840","article-title":"Efficacy and safety of tocilizumab in Beh\u00e7et\u2019s syndrome with refractory arterial lesions: a single-centre observational cohort study in China.","volume":"61","author":"Zhong","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R63-20260523","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3899\/jrheum.221106","article-title":"Tocilizumab in Beh\u00e7et disease: a multicenter study of 30 patients.","volume":"50","author":"Khitri","year":"2023","journal-title":"J Rheumatol"},{"key":"R64-20260523","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et\u2019s syndrome.","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R65-20260523","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et\u2019s syndrome.","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"R66-20260523","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et\u2019s disease: multicenter study of 124 patients.","volume":"62","author":"Vallet","year":"2015","journal-title":"J Autoimmun"},{"key":"R67-20260523","doi-asserted-by":"crossref","first-page":"e3348","DOI":"10.1097\/MD.0000000000003348","article-title":"Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet\u2019s syndrome: a Strobe-compliant observational study from a dedicated multidisciplinary center.","volume":"95","author":"Hatemi","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"R68-20260523","first-page":"1833","article-title":"Efficacy of infliximab in intestinal Beh\u00e7et\u2019s disease: a Korean multicenter retrospective study.","volume":"19","author":"Lee","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"R69-20260523","doi-asserted-by":"crossref","first-page":"EVIDoa2300354","DOI":"10.1056\/EVIDoa2300354","article-title":"Infliximab versus Cyclophosphamide for Severe Beh\u00e7et\u2019s Syndrome.","volume":"3","author":"Saadoun","year":"2024","journal-title":"NEJM Evid"},{"key":"R70-20260523","first-page":"keae585","article-title":"Infliximab versus interferon-alpha in the treatment of Beh\u00e7et\u2019s syndrome: clinical data from the BIO-BEH\u00c7ET\u2019S randomised controlled trial.","volume":"21","author":"Moots","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"R71-20260523","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1016\/S2665-9913(24)00194-2","article-title":"Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Beh\u00e7et\u2019s disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial.","volume":"6","author":"Zhong","year":"2024","journal-title":"Lancet Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:02:39Z","timestamp":1779530559000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":70,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044614","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-05-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}